Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hypersensitivity × High-Energy Shock Waves × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Leukemia, Myeloid, Acute 2 Infertility 2 Hodgkin Disease 2 Uterine Cervical Neoplasms 1 Thyroid Nodule 1 Thromboembolism 1 Stomach Neoplasms 1 Soft Tissue Neoplasms 1 Small Cell Lung Carcinoma 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Sarcoma 1 Risk Malignant Index 1 Renal Insufficiency, Chronic 1 Recurrence 1 Rectal Neoplasms 1 Popliteal Cyst 1 Polycystic Ovary Syndrome 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1

Interventions

Ultrasonography 2 tislelizumab 1 Mammography 1 Lenalidomide 1 Immune Checkpoint Inhibitors 1 High-Energy Shock Waves 1 Cetirizine 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02834585 2016-07-15

MUSTT

University of Genova

Hypersensitivity, Sarcoma, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡